Neuraxis Valuation
| NRXS Stock | 4.88 0.02 0.41% |
At this time, the firm appears to be overvalued. Neuraxis secures a last-minute Real Value of USD4.62 per share. The latest price of the firm is USD4.88. Our model forecasts the value of Neuraxis from analyzing the firm fundamentals such as Profit Margin of (2.24) %, current valuation of 47.88 M, and Return On Equity of -30.71 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Neuraxis' valuation include:
Price Book 22.6969 | Enterprise Value | Enterprise Value Ebitda (4.39) | Price Sales 15.3979 | Enterprise Value Revenue 14.2395 |
Overvalued
Today
Please note that Neuraxis' price fluctuation is unstable at this time. Calculation of the real value of Neuraxis is based on 3 months time horizon. Increasing Neuraxis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Neuraxis stock is determined by what a typical buyer is willing to pay for full or partial control of Neuraxis. Since Neuraxis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neuraxis Stock. However, Neuraxis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.88 | Real 4.62 | Target 5.0 | Hype 4.61 | Naive 4.3 |
The intrinsic value of Neuraxis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Neuraxis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Neuraxis helps investors to forecast how Neuraxis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neuraxis more accurately as focusing exclusively on Neuraxis' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Neuraxis' intrinsic value based on its ongoing forecasts of Neuraxis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Neuraxis' closest peers.
Neuraxis Cash |
|
Neuraxis Total Value Analysis
Neuraxis is now anticipated to have valuation of 47.88 M with market capitalization of 23.47 M, debt of 473.4 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Neuraxis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
47.88 M | 23.47 M | 473.4 K |
Neuraxis Investor Information
About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.05. Neuraxis had not issued any dividends in recent years. Based on the key indicators related to Neuraxis' liquidity, profitability, solvency, and operating efficiency, Neuraxis is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.Neuraxis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Neuraxis has an asset utilization ratio of 56.46 percent. This implies that the Company is making USD0.56 for each dollar of assets. An increasing asset utilization means that Neuraxis is more efficient with each dollar of assets it utilizes for everyday operations.Neuraxis Profitability Analysis
Based on Neuraxis' profitability indicators, Neuraxis may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in February. Profitability indicators assess Neuraxis' ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -7.4 M | Current Value -7.8 M | Quarterly Volatility 2.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.67 | 0.78 |
|
|
For Neuraxis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Neuraxis to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Neuraxis utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Neuraxis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Neuraxis over time as well as its relative position and ranking within its peers.
Neuraxis Earnings per Share Projection vs Actual
The next projected EPS of Neuraxis is estimated to be -0.21 with future projections ranging from a low of -0.21 to a high of -0.21. Neuraxis' most recent 12-month trailing earnings per share (EPS TTM) is at -1.05. Please be aware that the consensus of earnings estimates for Neuraxis is based on EPS before non-recurring items and includes expenses related to employee stock options.Neuraxis Earnings Estimation Breakdown
The calculation of Neuraxis' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Neuraxis is estimated to be -0.21 with the future projection ranging from a low of -0.21 to a high of -0.21. Please be aware that this consensus of annual earnings estimates for Neuraxis is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.21 Lowest | Expected EPS | -0.21 Highest |
Neuraxis Earnings Projection Consensus
Suppose the current estimates of Neuraxis' value are higher than the current market price of the Neuraxis stock. In this case, investors may conclude that Neuraxis is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Neuraxis' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 2 | 72.73% | -0.33 | -0.21 | -1.05 |
Neuraxis Ownership Allocation
The market capitalization of Neuraxis is USD23.47 Million. Neuraxis secures 18.89 % of its outstanding shares held by insiders and 15.38 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Neuraxis Profitability Analysis
The company reported the previous year's revenue of 2.69 M. Net Loss for the year was (8.24 M) with profit before overhead, payroll, taxes, and interest of 2.84 M.About Neuraxis Valuation
The stock valuation mechanism determines Neuraxis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Neuraxis based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuraxis. We calculate exposure to Neuraxis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neuraxis's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.7 M | 2.3 M | |
| Pretax Profit Margin | (3.53) | (3.71) | |
| Operating Profit Margin | (3.06) | (3.22) | |
| Net Loss | (3.53) | (3.71) | |
| Gross Profit Margin | 0.78 | 0.67 |
Neuraxis Current Valuation Indicators
Neuraxis' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Neuraxis' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Neuraxis, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Neuraxis' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Neuraxis' worth.Additional Tools for Neuraxis Stock Analysis
When running Neuraxis' price analysis, check to measure Neuraxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuraxis is operating at the current time. Most of Neuraxis' value examination focuses on studying past and present price action to predict the probability of Neuraxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuraxis' price. Additionally, you may evaluate how the addition of Neuraxis to your portfolios can decrease your overall portfolio volatility.